-
UK launch for Vagirux
pharmatimes
December 08, 2020
Gedeon Richter has announced the UK launch of Vagirux (estradiol hemihydrate) for the treatment of vaginal atrophy due to oestrogen deficiency in postmenopausal women with or without a uterus.
-
Pfizer-BioNTech COVID-19 vaccine gets EUA approval from the UK
expresspharma
December 03, 2020
Care home residents, health and care staff, the elderly and people who are clinically extremely vulnerable will be first in line.
-
Survey finds 64 percent of UK adults would receive COVID-19 vaccine
europeanpharmaceuticalreview
December 02, 2020
A survey of 1,500 adults in the UK showed that most would be happy to receive a COVID-19 vaccine, while nine percent said they would be unlikely to get the vaccine.
-
UK PM visits Wockhardt facility in North Wales
expresspharma
December 02, 2020
The UK Government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.
-
UK secures total of 357 million doses of various COVID-19 vaccines
europeanpharmaceuticalreview
December 01, 2020
After purchasing an additional two million doses of Moderna’s COVID-19 vaccine, the UK will now receive a total of 357 million doses of vaccines from seven developers.
-
UK announces £20 million investment into medicine manufacturing
europeanpharmaceuticalreview
December 01, 2020
UK Prime Minister Boris Johnson has announced a £20 million investment fund for medicine manufacturing and supply chains in the UK.
-
Government funding for UK biomedical innovation insufficient, BIA says
europeanpharmaceuticalreview
November 26, 2020
According to the BIA, less than four percent of eligible projects received funding from a government programme for early-stage biotech companies.
-
COVID-19 pandemic has emphasised existing health inequalities, research finds
pharmatimes
November 25, 2020
Research conducted by Imperial College London in partnership with Philips UK has found that the COVID-19 pandemic has highlighted existing healthcare inequalities in the UK.
-
UK and US could administer first approved COVID-19 vaccines next month
europeanpharmaceuticalreview
November 24, 2020
Both the UK and US have said that, if approved, the Pfizer and BioNTech COVID-19 vaccine could be administered to people as early as December.
-
Annual pharma R&D spending in UK climbed 6.9% in 2019
pharmatimes
November 24, 2020
Annual research and development (R&D) spending in the UK’s pharmaceutical sector climbed by 6.9% last year, representing an eight-year high point, according to tax relief specialist Catax.